80
Views
4
CrossRef citations to date
0
Altmetric
Review

Comprehensive review of visual defects reported with topiramate

, , , &
Pages 983-992 | Published online: 23 May 2017

References

  • Topamax. Prescribing information [Internet] Available from: https://www.topamax.com/sites/default/files/topamax.pdfAccessed July 12, 2016
  • ShankRPGardockiJFStreeterAJMaryanoffBEAn overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of actionEpilepsia200041Suppl 1S3S9
  • KuznieckyRHoSPanJModulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adultsNeurology200258336837211839834
  • PetroffOARothmanDLBeharKLMattsonRHHuman brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing doseNeurology1996465145914638628502
  • SillsGJButlerEForrestGRatnarajNPatsalosPNBrodieMJVigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retinaEpilepsia200344788689212823570
  • ErranteLDPetroffOACAcute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrationsSeizure200312530030612810343
  • SchieferUVisual field defects – essentials for neurologistsJ Neurol2003250440741112760380
  • FraunfelderFWFraunfelderFTKeatesEUTopiramate-associated acute, bilateral, secondary angle-closure glaucomaOphthalmology2004111110911114711721
  • MandalAChatterjeeSBoseSGangulyGOcular adverse effects of topiramate: two case reportsIndian J Pharmacol200840627828021279186
  • QuagliatoLBBarellaKAbreu NetoJMQuagliatoEMTopiramate-associated acute, bilateral, angle-closure glaucoma: case reportArq Bras Oftalmol2013761484923812529
  • KjellströmSBruunAIsakssonBErikssonTAndréassonSPonjavicVRetinal function and histopathology in rabbits treated with topiramateDoc Ophthalmol2006113317918617111186
  • KälviäinenRNousiainenIVisual field defects with vigabatrin: epidemiology and therapeutic implicationsCNS Drugs200115321723011463129
  • WildJMMartinezCReinshagenGHardingGFCharacteristics of a unique visual field defect attributed to vigabatrinEpilepsia199940121784179410612345
  • YonedaSTanakaEGotoWOtaTHaraHTopiramate reduces excitotoxic and ischemic injury in the rat retinaBrain Res20039671–225726612650986
  • AltmanDGPractical Statistics for Medical ResearchBoca Raton, FLChapman & Hall/CRC1991611
  • NousiainenDIMäntyjärviMKälviäinenRVisual function in patients treated with the GABAergic anticonvulsant drug tiagabineClin Drug Investig2012206393400
  • SillsGJPatsalosPNButlerEForrestGRatnarajNBrodieMJVisual field constriction: accumulation of vigabatrin but not tiagabine in the retinaNeurology200157219620011468302
  • VerrottiALobefaloLPrioloTColor vision in epileptic adolescents treated with valproate and carbamazepineSeizure200413641141715276145
  • ChristensenJAndreasenFPoulsenJHDamMRandomized, concentration-controlled trial of topiramate in refractory focal epilepsyNeurology20036191210121814610122
  • ArndtCFSalleMDeramburePHDefoort-DhellemmesSHacheJ-CThe effect on vision of associated treatments in patients taking vigabatrin: carbamazepine versus valproateEpilepsia200243881281712180998
  • PaulusWSchwarzGSteinhoffBJThe effect of anti-epileptic drugs on visual perception in patients with epilepsyBrain J Neurol1996119Pt 2539549
  • VerrottiAMancoRMatricardiSFranzoniEChiarelliFAntiepileptic drugs and visual functionPediatr Neurol200736635336017560495
  • ZaccaraGPeruccaPGangemiPFThe adverse event profile of pregabalin across different disorders: a meta-analysisEur J Clin Pharmacol201268690391222271298
  • DubocAHanoteauNSimonuttiMVigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in ratsAnn Neurol200455569570515122710
  • PandayVARheeDJReview of sulfonamide-induced acute myopia and acute bilateral angle-closure glaucomaCompr Ophthalmol Update20078527127618201514
  • ThambiLKapcalaLPChambersWTopiramate-associated secondary angle-closure glaucoma: a case seriesArch Ophthalmol20021208110812149075
  • TripathiRCTripathiBJHaggertyCDrug-induced glaucomas: mechanism and managementDrug Saf2003261174976712908846
  • IkedaNIkedaTNagataMMimuraOCiliochoroidal effusion syndrome induced by sulfa derivativesArch Ophthalmol200212012177512470170
  • NateshSRajashekharaSKRaoASDShettyBTopiramate-induced angle closure with acute myopia, macular striaeOman J Ophthalmol201031262820606870
  • TanakaSChumanYAkaikeKDoiWA case of topiramate-induced angle closure glaucomaNihon Shinkei Seishin Yakurigaku Zasshi2011313131133 Japanese21800704
  • SpaccapeloLLeschiuttaSAureaCFerrariATopiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-reportCases J2009218719171058
  • WillettMCEdwardDPRefractory topiramate-induced angle-closure glaucoma in a man: a case reportJ Med Case Reports2011533
  • Asensio-SánchezVMTorreblanca-AgüeraBMartínez-CalvoSCalvoMJRodríguezRSevere ocular side effects with TopamaxArch Soc Esp Oftalmol2006816345348 Spanish16804780
  • ForoozanRBuonoLMFoggy visual field defectSurv Ophthalmol200348444745112850232
  • MacgregorEARosenbergJDKurthTSex-related differences in epidemiological and clinic-based headache studiesHeadache201151684385921631472
  • McHughJCDelantyNEpidemiology and classification of epilepsy: gender comparisonsInt Rev Neurobiol200883112618929074
  • Al AjlouniSShormanADaoudASThe efficacy and side effects of topiramate on refractory epilepsy in infants and young children: a multi-center clinical trialSeizure200514745946316087357
  • ChungSSA review of the efficacy and safety of extended-release topiramate in the adjunctive treatment for refractory partial-onset seizuresTher Adv Neurol Disord20158313113625941540
  • ChungSSFakhouryTAHoganREOnce-daily USL255 as adjunctive treatment of partial-onset seizures: randomized phase III studyEpilepsia20145571077108724902983